Search research articles
Contact Us
Filters
Showing results (131-140 of 204) with videos related to
Page
of 21
Sort By:
The Journal of Clinical Investigation
|
October 2, 2012
Spleens of myelofibrosis patients contain malignant hematopoietic stem cells
Xiaoli Wang, Sonam Prakash, Min Lu, et al.
Leukemia & Lymphoma
|
November 13, 2019
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis
Douglas Tremblay, Amber King, Lihua Li, et al.
Experimental Hematology
|
February 2, 2002
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
Amelia Bartholomew, Cord Sturgeon, Mandy Siatskas, et al.
Experimental Hematology
|
January 22, 2008
Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease
Anna Rita Migliaccio, Fabrizio Martelli, Maria Verrucci, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 8, 2016
Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms
Irum Khan, Ardaman Shergill, Santosh L Saraf, et al.
Scientific Reports
|
November 14, 2019
Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Manali Sapre, Douglas Tremblay, Eric Wilck, et al.
Experimental Hematology
|
July 21, 2009
Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms
Xiaoli Wang, Amanda LeBlanc, Steven Gruenstein, et al.
Leukemia Research
|
December 9, 2016
A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
John Mascarenhas, Lonette Sandy, Min Lu, et al.
Pediatric Blood & Cancer
|
December 31, 2020
Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia
Nicole Kucine, Shayla Bergmann, Spencer Krichevsky, et al.
Blood
|
June 7, 2019
Oral idasanutlin in patients with polycythemia vera
John Mascarenhas, Min Lu, Heidi Kosiorek, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 204) with videos related to
Sort By:
Page
of 21
The Journal of Clinical Investigation
|
October 2, 2012
Spleens of myelofibrosis patients contain malignant hematopoietic stem cells
Xiaoli Wang, Sonam Prakash, Min Lu, et al.
Leukemia & Lymphoma
|
November 13, 2019
Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis
Douglas Tremblay, Amber King, Lihua Li, et al.
Experimental Hematology
|
February 2, 2002
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
Amelia Bartholomew, Cord Sturgeon, Mandy Siatskas, et al.
Experimental Hematology
|
January 22, 2008
Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease
Anna Rita Migliaccio, Fabrizio Martelli, Maria Verrucci, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 8, 2016
Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms
Irum Khan, Ardaman Shergill, Santosh L Saraf, et al.
Scientific Reports
|
November 14, 2019
Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Manali Sapre, Douglas Tremblay, Eric Wilck, et al.
Experimental Hematology
|
July 21, 2009
Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms
Xiaoli Wang, Amanda LeBlanc, Steven Gruenstein, et al.
Leukemia Research
|
December 9, 2016
A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
John Mascarenhas, Lonette Sandy, Min Lu, et al.
Pediatric Blood & Cancer
|
December 31, 2020
Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia
Nicole Kucine, Shayla Bergmann, Spencer Krichevsky, et al.
Blood
|
June 7, 2019
Oral idasanutlin in patients with polycythemia vera
John Mascarenhas, Min Lu, Heidi Kosiorek, et al.
Page
of 21